Intratumoral and peritumoral heterogeneity based on CT to predict the pathological response after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
Open Access
- 19 September 2025
- journal article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 314-324
Abstract
Background: Neoadjuvant chemoimmunotherapy (NACI) regimen (camrelizumab plus paclitaxel and nedaplatin) has shown promising potential in patients with esophageal squamous cell carcinoma (ESCC), but accurately predicting the therapeutic response remains a challenge. Objective: To develop and validate a CT-based machine learning model that incorporates both intratumoral and peritumoral heterogeneity for predicting the pathological response of ESCC patients after NACI. Methods: Patients with ESCC who underwent surgery following NACI between June 2020 and July 2024 were included retrospectively and prospectively. Univariate and multivariate logistic regression analyses were performed to identify clinical variables associated with pathological response. Traditional radiomics features and habitat radiomics features from the intratumoral and peritumoral regions were extracted from posttreatment CT images, and 6 predictive models were established using 14 machine learning algorithms. The combined model was developed by integrating intratumoral and peritumoral habitat radiomics features with clinical variables. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 157 patients (mean [SD] age, 59.6 [6.5] years) were enrolled in our study, of whom 60 (38.2%) achieved major pathological response (MPR) and 40 (25.5%) achieved pathological complete response (pCR). The combined model demonstrated excellent predictive ability for MPR after NACI, with an AUC of 0.915 (95% CI: 0.844–0.981), accuracy of 0.872, sensitivity of 0.733, and specificity of 0.938 in the test set. In sensitivity analysis focusing on pCR, the combined model exhibited robust performance, with an AUC of 0.895 (95% CI: 0.782 – 0.980) in the test set. Conclusion: The combined model integrating intratumoral and peritumoral habitat radiomics features with clinical variables can accurately predict MPR in ESCC patients after NACI and shows promising potential in predicting pCR.Keywords
This publication has 29 references indexed in Scilit:
- The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint InhibitorsCancer Research and Treatment, 2021
- Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinomaJournal of Thoracic Disease, 2021
- Machine learning in clinical decision makingMed, 2021
- Global burden and epidemiology of Barrett oesophagus and oesophageal cancerNature Reviews Gastroenterology & Hepatology, 2021
- Tumor Heterogeneity: A Great Barrier in the Age of Cancer ImmunotherapyCancers, 2021
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 2021
- Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell CarcinomaJAMA Network Open, 2020
- Machine Learning in oncology: A clinical appraisalCancer Letters, 2020
- Radiomics: the bridge between medical imaging and personalized medicineNature Reviews Clinical Oncology, 2017
- Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experienceCancer, 2017